Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Palmoplantar pustulosis present for at least one year~* Symmetrical foot lesions with at least 5% of the skin surface involvement~* Difference less than or equal to 10% extension of lesions on both sides of the body~* Suspension for over 3 months from start of the study of any systemic drugs for psoriasis, immunosuppressive treatments (cyclosporine, systemic steroids), psoralen plus ultraviolet A irradiation (PUVA) or ultraviolet B phototherapy (UVB)~Exclusion Criteria:~* Nonsymmetrical foot lesions or less than 5% of the skin surface involvement~* Difference of more than 10% extension of lesions on both sides of the body~* Patients who have performed, within 3 months before inclusion in the study, treatments with systemic drugs for psoriasis, immunosuppressive treatments (cyclosporine, systemic steroids), psoralen plus ultraviolet A irradiation (PUVA) or ultraviolet B phototherapy (UVB)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- TEPSO socks (Type: EXPERIMENTAL): This arm include all patients sides (left or right) treated with TEPSO socks.
- Standard socks (Type: PLACEBO_COMPARATOR): This arm include all patients sides (left or right) treated with standard cotton socks.

Based on this trial design, predict the completion outcome and termination type (if applicable).